Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Shook David acquired 23,421 shares (grant or award)
  3. 4 Planned sale Chief Legal Officer sold 3,396 shares at $8.00 ($27,168)
  4. 4 Open-market sale Chief Scientific Officer sold 456 shares at $5.60 ($2,554)
  5. 4 Open-market sale Chief Executive Officer sold 1,770 shares at $5.60 ($9,912)
  6. 4 Open-market sale Chief Medical Officer sold 456 shares at $5.60 ($2,554)
  7. 4 Open-market sale Chief Legal Officer sold 727 shares at $5.60 ($4,071)
  8. 4 Open-market sale Chief Technical Officer sold 229 shares at $5.60 ($1,282)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Director bought 3,000,000 shares at $10.00 ($30,000,000)
  19. 4 Open-market buy Director bought 2,000,000 shares at $10.00 ($20,000,000)
  20. 4 Returned to the company Chief Executive Officer returned 150,000 shares (to the company)

Page 3 of 11 · 218 filings